Furthermore, patients with highly phosphorylated Drp1 proteins are associated with the increased risk on developing tumor relapse after neoadjuvant chemoradiotherapy (neoCRT) treatment in locally advanced rectal cancer (LARC). This evidence concerns the gene DNM1L and neoplasm.